ScholarWorks@Hanyang University

Browsing by Park, Cheol-YoungAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 20 of 31

SCIESCOPUS
Acromegaly and cardiovascular outcomes: a cohort studyGo to Link

Hong, Sangmo; Kim, Kyung-Soo; Han, Kyungdo; Park, Cheol-Young

ArticleIssue Date2022CitationEUROPEAN HEART JOURNAL, v.43, no.15, pp.1491 - 1499PublisherOXFORD UNIV PRESS
SCOPUSKCI
Assessing the Validity of the Criteria for the Extreme Risk Category of Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based StudyGo to Linkopen access

Kim, Kyung-Soo; Hong, Sangmo; Han, Kyungdo; Park, Cheol-Young

ArticleIssue Date2022CitationJournal of Lipid and Atherosclerosis, v.11, no.1, pp.73 - 83PublisherKorean Society of Lipid and Atherosclerosis
SCIESCOPUS
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based studyGo to Link

Kim, Kyung-Soo; Hong, Sangmo; Han, Kyungdo; Park, Cheol-Young

ArticleIssue Date2024CitationBMJ-British Medical Journal, v.384, pp 1 - 12PublisherBritish Medical Association
SCIESCOPUS
Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortalityGo to Linkopen access

Han, Eugene; Han, Kyung-Do; Lee, Yong-ho; Kim, Kyung-Soo; Hong, Sangmo; Park, Jung Hwan; Park, Cheol-Young

ArticleIssue Date2025CitationCardiovascular Diabetology, v.24, no.1, pp 1 - 10PublisherBioMed Central
SCIESCOPUS
Comparison between the Therapeutic Effect of Metformin, Glimepiride and Their Combination as an Add-On Treatment to Insulin Glargine in Uncontrolled Patients with Type 2 DiabetesGo to Link

Park, Cheol-Young; Kang, Jun Goo; Chon, Suk; Noh, Junghyun; Oh, Seung Joon; Lee, Chang Beom; Park, Sung Woo

ArticleIssue Date2014CitationPLoS ONE, v.9, no.3, pp 1 - 7PublisherPublic Library of Science
SCIESCOPUS
Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort studyGo to Linkopen access

Hong, Sangmo; Han, Kyungdo; Kim, Kyung-Soo; Park, Cheol-Young

ArticleIssue Date2025CitationCardiovascular Diabetology, v.24, no.1, pp 1 - 10PublisherBioMed Central
SCIESCOPUS
Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extensionGo to Link

Hong, Sang-Mo; Park, Cheol-Young; Hwang, Dong-Min; Han, Kyung Ah; Lee, Chang Beom; Chung, Choon Hee; Yoon, Kun-Ho; Mok, Ji-Oh; Park, Kyong Soo; Park, Sung-Woo

ArticleIssue Date2017CitationDiabetes, Obesity and Metabolism, v.19, no.5, pp 654 - 663PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D studyGo to Linkopen access

Kim, Kyung-Soo; Han, Kyung Ah; Kim, Tae Nyun; Park, Cheol-Young; Park, Jung Hwan; Kim, Sang Yong; Kim, Yong Hyun; Song, Kee Ho; Kang, Eun Seok; Kim, Chul Sik, et al.

ArticleIssue Date2023CitationDIABETES & METABOLISM, v.49, no.4, pp.1 - 10PublisherMASSON EDITEUR
SCIESCOPUS
Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trialsGo to Linkopen access

Lyu, Young Sang; Hong, Sangmo; Lee, Si Eun; Cho, Bo Young; Park, Cheol-Young

ArticleIssue Date2024CitationCardiovascular Diabetology, v.23, no.1, pp 1 - 11PublisherBioMed Central
SCIESCOPUS
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)Go to Linkopen access

Kim, Gyuri; Lim, Soo; Kwon, Hyuk-Sang; Park, Ie B.; Ahn, Kyu J.; Park, Cheol-Young; Kwon, Su K.; Kim, Hye S.; Park, Seok W.; Kim, Sin G., et al.

ArticleIssue Date2020CitationDIABETES OBESITY & METABOLISM, v.22, no.9, pp.1527 - 1536PublisherWILEY
SCIESCOPUS
Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)Go to Linkopen access

Hong, Sangmo; Kim, Won J.; Kim, Sungrae; Park, Jung H.; Kang, Eun S.; Moon, Min K.; Kim, Jae T.; Mok, Ji-Oh; Lee, Ki Y.; Park, Cheol-Young, et al.

ArticleIssue Date2026CitationDIABETES OBESITY & METABOLISM, v.28, no.2, pp 906 - 913PublisherWILEY
SCISCIESCOPUSKCI
Elevation of Morning Blood Pressure in Sodium Resistant Subjects by High Sodium DietGo to Link

Rhee, Moo-Yong; Lim, Chi-Yeon; Shin, Sung-Joon; Oh, Sang-Woo; Park, Yong-Soon; Kim, Jong-Wook; Park, Hye-Kyoung; Kim, Cho-il; Park, Cheol-Young; Kim, Sun-Woong

ArticleIssue Date2013CitationJournal of Korean Medical Science, v.28, no.4, pp 555 - 563Publisher대한의학회
SCIESCOPUS
Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levelsGo to Link

Kim, Kyung-Soo; Hong, Sangmo; Han, Kyungdo; Park, Cheol-Young

ArticleIssue Date2022CitationMetabolism: Clinical and Experimental, v.137, pp 1 - 8PublisherElsevier BV
SCIESCOPUS
Fenofibrate and risk of end-stage renal disease: A nationwide cohort studyGo to Linkopen access

Hyun, Young Youl; Kim, Kyung-Soo; Hong, Sangmo; Han, Kyungdo; Park, Cheol-Young

ArticleIssue Date2024CitationDiabetes, Obesity and Metabolism, v.26, no.10, pp 4583 - 4590PublisherJohn Wiley and Sons Inc
SCIESCOPUSKCI
From Old to New: A Comprehensive Review of Obesity Diagnostic Criteria and Their ImplicationsGo to Linkopen access

Hong, Sangmo; Park, Cheol-Young

ArticleIssue Date2025CitationEndocrinology and Metabolism, v.40, no.4, pp 517 - 522Publisher대한내분비학회
SCOPUSESCIKCI
Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey

Hong, Sangmo; Kang, Jun Goo; Kim, Chul Sik; Lee, Seong Jin; Park, Cheol-Young; Lee, Chang Beom; Ihm, Sung-Hee

ArticleIssue Date2016CitationDiabetes and Metabolism Journal, v.40, no.2, pp 167 - 170Publisher대한당뇨병학회
SCIESCOPUS
Incidence of bronchiectasis in patients with acromegaly: a cohort studyGo to Linkopen access

Gil, Hyun-Il; Han, Kyungdo; Hong, Sangmo; Park, Cheol-Young

ArticleIssue Date2024CitationFrontiers in Endocrinology, v.15, pp 1 - 7PublisherFrontiers Media S.A.
SCIESCOPUSKCI
Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 InhibitorsGo to Linkopen access

Hong, Sangmo; Jung, Chang Hee; Han, Song; Park, Cheol-Young

ArticleIssue Date2022CitationDIABETES & METABOLISM JOURNAL, v.46, no.1, pp.63 - 70PublisherKOREAN DIABETES ASSOC
SCIESCOPUSKCI
Long-Term Prognosis and Systemic Impact of Acromegaly: Analyses Utilizing Korean National Health Insurance DataGo to Linkopen access

Hong, Sangmo; Han, Kyungdo; Park, Cheol-Young

ArticleIssue Date2025CitationENDOCRINOLOGY AND METABOLISM, v.40, no.1, pp 1 - 9PublisherKOREAN ENDOCRINE SOC
SCIESCOPUSKCI
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort StudyGo to Linkopen access

Kim, Kyung-Soo; Hong, Sangmo; Ahn, Hong-Yup; Park, Cheol-Young

ArticleIssue Date2023CitationDIABETES&METABOLISM JOURNAL, v.47, no.2, pp.220 - 231PublisherKOREAN DIABETES ASSOC
1 2
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어